Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Corifollitropin alfa: Phase II data

Data from 50 women undergoing ovarian stimulation in the open-label, uncontrolled Phase II REALIZE

Read the full 140 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE